Searching News Database: AZUR
HSMN NewsFeed - 3 Jul 2025
Novartis Provides Update on Phase III GCAptAIN Study of Cosentyx(R) in Giant Cell Arteritis (GCA)
Novartis Provides Update on Phase III GCAptAIN Study of Cosentyx(R) in Giant Cell Arteritis (GCA)
HSMN NewsFeed - 14 Jul 2021
Terumo Introduces New AZUR(TM) Vascular Plug and PG Pro(TM) Peripheral Microcatheter Embolization System
Terumo Introduces New AZUR(TM) Vascular Plug and PG Pro(TM) Peripheral Microcatheter Embolization System
HSMN NewsFeed - 10 Oct 2013
RaySearch Laboratories: Institut Paoli-Calmettes becomes first RayStation(R) reference clinic in France
RaySearch Laboratories: Institut Paoli-Calmettes becomes first RayStation(R) reference clinic in France
HSMN NewsFeed - 8 Oct 2013
Terumo Interventional Systems Launches The Detachable AZUR(R) CX Peripheral Coil System
Terumo Interventional Systems Launches The Detachable AZUR(R) CX Peripheral Coil System
HSMN NewsFeed - 18 Jan 2012
Jazz Pharmaceuticals and Azur Pharma Combine to Create Jazz Pharmaceuticals plc
Jazz Pharmaceuticals and Azur Pharma Combine to Create Jazz Pharmaceuticals plc
HSMN NewsFeed - 6 Apr 2010
Fibrocell Science, Inc. Announces Addition of Marc B. Mazur to Board of Directors
Fibrocell Science, Inc. Announces Addition of Marc B. Mazur to Board of Directors
HSMN NewsFeed - 2 Feb 2009
Molecular Insight Pharmaceuticals Announces Board and Senior Management Appointments
Molecular Insight Pharmaceuticals Announces Board and Senior Management Appointments
HSMN NewsFeed - 9 Jan 2009
Azur Pharma Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB
Azur Pharma Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB
HSMN NewsFeed - 22 Sep 2008
Molecular Insight Pharmaceuticals, Inc. Adds Four Healthcare Industry Experts to Board of Directors
Molecular Insight Pharmaceuticals, Inc. Adds Four Healthcare Industry Experts to Board of Directors
HSMN NewsFeed - 3 Jul 2007
Azur Pharma Announces the Acquisition of FazaClo for $42 Million Plus Contingent Milestones
Azur Pharma Announces the Acquisition of FazaClo for $42 Million Plus Contingent Milestones
HSMN NewsFeed - 3 Jul 2007
AVANIR Pharmaceuticals Announces Sale of FazaClo to Fund Continued Development of Zenvia
AVANIR Pharmaceuticals Announces Sale of FazaClo to Fund Continued Development of Zenvia
Additional items found! 5
Members Archive contains
5 additional stories matching:
AZUR
(Password required)
AZUR
(Password required)
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!